Imperial Capital, a private equity fund in Toronto, Canada, closed its fourth fund yesterday with $126 million. Interestingly, they kicked off Fund IV with an investment in Schulman Associates, an independent Institutional Review Board (IRB) company based in Cincinnati, Ohio, that provides:
“IRB services for a variety of study types (primarily Phase II and III multi-site clinical trials) within the United States, Puerto Rico, and Canada”
which will hopefully avoid any Coast-like problems. Imperial Capital’s other current investments are in cosmetics, hair care and paintball.
H/T to @CVCACanada.
